Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02446587 · ClinicalTrials.gov registry record
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 500
- Enrollment target
NCT02446587: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02446587 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02446587 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
SELECT is a multicenter, observational prospective study implementing a protocol to acquire imaging and clinical variables known to affect clinical outcomes after endovascular therapy in an effort to evaluate and compare the different selection methods and criteria currently used in practice for acute ischemic stroke patients in the anterior circulation with large vessel occlusion. The study aim is to evaluate prospectively different selection methodologies for endovascular therapy, to compare them against each other to identify which method provides the highest predictive ability in the selection of patients for IAT and to devise a formula that predicts patients' outcomes. This study will enroll patients based on the recent AHA guidelines (July 2015) regarding treatment of patients with acute ischemic strokes and large artery occlusions in the anterior circulation. Our goal is to collect complete imaging, clinical, and 90 day follow up data on 250 endovascular therapy patients as well as up to 250 concurrent medical management patients as a comparison group.
Primary Outcome
Favorable primary clinical outcome will be patients functional outcomes at 90 (+/- 15) days measured by modified Rankin scale (mRS) score 0-2
Interventions
- DEVICE Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-05 |
What the finished NCT02446587 record still lists
NCT02446587 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mechanical Thrombectomy is the first listed.
NCT02446587 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02446587 about?
NCT02446587 is a clinical study titled "Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke". SELECT is a multicenter, observational prospective study implementing a protocol to acquire imaging and clinical variables known to affect clinical outcomes after endovascular therapy in an effort to evaluate and compare the different selection methods and criteria currently used in practice for acu...
What is the current status of trial NCT02446587?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2016-01. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02446587?
The interventions under investigation include: Mechanical Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT02446587?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia